Author

Jacquelynn N. Copeland

Observed names: J.N. Copeland, JACQUELYNN COPELAND, Jacquelynn Copeland

Observed institutions: Barrow Neurological Institute, Harvard University, Johns Hopkins University, University of Alabama at Birmingham, Massachusetts General Hospital, Birmingham VA Medical Center, Banner Alzheimer’s Institute, UAB Medicine, Risques, écosystèmes, vulnérabilité, environnement, résilience

OpenAlex ID: A5012910243

Neurocognitive predictors of financial capacity across the dementia spectrum: Normal aging, mild cognitive impairment, and Alzheimer’s disease

2009 · MEGAN G. SHEROD, H. RANDALL GRIFFITH, et al. · Journal of the International Neuropsychological Society · 152

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

2021 · Daniel K Burns, Robert C Alexander, et al. · The Lancet Neurology · 129

Sex Differences in Long COVID

2025 · Dimpy P. Shah, Tanayott Thaweethai, et al. · JAMA Network Open · 119

2024 Update of the RECOVER-Adult Long COVID Research Index

2024 · Linda N. Geng, Kristine M. Erlandson, et al. · JAMA · 89

Magnetic Resonance Imaging Volume of the Angular Gyri Predicts Financial Skill Deficits in People with Amnestic Mild Cognitive Impairment

2010 · H. Randall Griffith, Christopher C. Stewart, et al. · Journal of the American Geriatrics Society · 70

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study

2024 · Zoe Swank, Ella Borberg, et al. · Clinical Microbiology and Infection · 58

MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer’s disease

2013 · Luke E. Stoeckel, Christopher C. Stewart, et al. · Brain Imaging and Behavior · 56

Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort

2024 · Kristine M. Erlandson, Linda N. Geng, et al. · Annals of Internal Medicine · 54

Accuracy of Patient and Care Partner Identification of Cognitive Impairments in Parkinson's Disease–Mild Cognitive Impairment

2016 · Jacquelynn N. Copeland, Abraham Lieberman, et al. · Movement Disorders · 48

Evaluation of Interventions for Cognitive Symptoms in Long COVID

2025 · David S. Knopman, Deborah Koltai, et al. · JAMA Neurology · 11

Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort

2025 · Leora I. Horwitz, Jacqueline H. Becker, et al. · JAMA Network Open · 9

Characterization and validation of EHR computable phenotypes for Long COVID using patient-reported symptoms: insights from the nationwide RECOVER program

2026 · Victor M Castro, Vivian Gainer, et al. · Journal of the American Medical Informatics Association

To Scan or Not to Scan

2018 · David A. Weidman, Anna D. Burke, et al. · The Primary Care Companion For CNS Disorders

Mood Versus Memory

2017 · Anna D. Burke, William J. Burke, et al. · The Primary Care Companion For CNS Disorders

At a Loss for Words

2016 · David A. Weidman, Anna D. Burke, et al. · The Primary Care Companion For CNS Disorders

Patient and Caregiver Accuracy in Reporting Objectively Verified Neuropsychological Deficits Among Deep Brain Stimulation Candidates with Parkinson’s Disease and Mild Cognitive Impairment

2015 · A.I. Tröster, J.N. Copeland, et al. · Brain stimulation

Social problem-solving abilities and health behaviors among injured service members

2013 · Cady K. Block, Laurie Malone, et al. · PsycEXTRA Dataset

Works count: 17

Citation count: 795

H-index: 10

I10-index: 10